Orlandi, C.; Conti, I.; Torre, D.; Barocci, S.; Magnani, M.; Stefanetti, G.; Casabianca, A.
Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines 2025, 13, 1031.
https://doi.org/10.3390/vaccines13101031
AMA Style
Orlandi C, Conti I, Torre D, Barocci S, Magnani M, Stefanetti G, Casabianca A.
Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines. 2025; 13(10):1031.
https://doi.org/10.3390/vaccines13101031
Chicago/Turabian Style
Orlandi, Chiara, Ilaria Conti, Davide Torre, Simone Barocci, Mauro Magnani, Giuseppe Stefanetti, and Anna Casabianca.
2025. "Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions" Vaccines 13, no. 10: 1031.
https://doi.org/10.3390/vaccines13101031
APA Style
Orlandi, C., Conti, I., Torre, D., Barocci, S., Magnani, M., Stefanetti, G., & Casabianca, A.
(2025). Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines, 13(10), 1031.
https://doi.org/10.3390/vaccines13101031
